TellWell
…
← Misinformation tracker
UnverifiableNews · Health

Yes, Unregulated Stem Cell Clinics Have Caused Blindness, Tumors, and Infections — The FDA Has the Records to Prove It

“The FDA has documented serious complications from under-regulated stem cell applications including blindness, tumor formation, and infections”

The argument in brief

Some people question whether stem cell clinics are truly dangerous or whether safety concerns are overblown. The evidence is clear: unregulated stem cell treatments in the U.S. have caused permanent blindness, tumor growth, serious infections, and death. The strongest proof comes from a 2017 New England Journal of Medicine study documenting three patients who went permanently blind after receiving injections at a Florida clinic operating outside FDA oversight.

The numbersDocumented U.S. Stem Cell Clinic Adverse Event Categories (FDA & Published Reports)

Data: FDA Warning Letters, NEJM 2017, Stem Cell Reports 2018

Why it spread

People share this because the outcomes — blindness, tumors — are viscerally alarming, and because many already feel uneasy about the booming wellness and regenerative medicine industry. It also validates a reasonable instinct: that when profit-driven clinics operate in regulatory gray zones, patients get hurt. The emotional weight of the stories makes them easy to pass along, and in this case, the underlying concern is fully justified by the evidence.

The claim is straightforward and it is true. The FDA has formally documented serious, sometimes permanent harms caused by unregulated stem cell clinics operating across the United States. These are not hypothetical risks or rare theoretical side effects — they are recorded in court documents, federal databases, and peer-reviewed medical journals.

The blindness cases are the most striking. A 2017 study in the New England Journal of Medicine by Kuriyan and colleagues described three patients who paid a Florida clinic to treat macular degeneration with stem cell injections. All three suffered severe vision loss, retinal detachment, and in some cases permanent blindness. The clinic had no FDA approval and no clinical trial oversight. These patients went in with partial vision and came out unable to see.

Tumor formation is also documented, not just theorized. A 2018 case report in Stem Cell Reports described a patient who developed a glioproliferative lesion — an abnormal tumor-like growth — after receiving stem cell injections into the spinal canal at an unregulated clinic. Separately, JAMA Internal Medicine published an analysis of FDA adverse event data in 2018 confirming infections, neurological damage, and vision loss across multiple patients nationwide.

The scale of the problem is large. A 2016 survey in Nature Medicine identified over 570 U.S. businesses marketing unproven stem cell treatments. The FDA has issued warning letters to many of them and won a permanent federal injunction in 2021 against one Florida clinic after documenting patient harms including infections and vision loss. The courts sided with the FDA precisely because the evidence of harm was solid.

To be fair to the strongest version of the opposing view: legitimate, FDA-approved stem cell therapies do exist and have saved lives, particularly in blood cancer treatment. The problem is not stem cell science itself — it is the booming market of clinics charging thousands of dollars for unproven procedures with no regulatory checks. That distinction matters.

This story spreads because the outcomes are dramatic and the industry is genuinely large and loosely policed. If you encounter a clinic promising stem cell cures for conditions ranging from arthritis to autism, the key question to ask is simple: is this part of an FDA-approved trial? If the answer is no, the documented risks are real.

Sources

  • New England Journal of Medicine (Kuriyan et al., 2017)

    Three patients who received stem cell injections at a Florida clinic for macular degeneration suffered severe bilateral vision loss, retinal detachment, and in some cases permanent blindness. The clinic operated outside FDA oversight.

  • FDA Safety Alert and Warning Letters

    The FDA has issued multiple warning letters to stem cell clinics and documented adverse events including infections, blindness, tumor formation, and death associated with unapproved stem cell products.

  • Nature Medicine (Turner & Knoepfler, 2016)

    A systematic survey identified over 570 U.S. businesses marketing unproven stem cell interventions, highlighting the scale of the under-regulated industry and associated patient safety risks.

  • FDA vs. US Stem Cell Clinic LLC (11th Circuit Court, 2021)

    Federal courts upheld FDA authority to regulate stem cell clinics after the agency documented patient harms including infections and vision loss from unapproved adipose-derived stem cell treatments.

  • Stem Cell Reports (Berkowitz et al., 2018)

    Case reports documented tumor formation (glioproliferative lesion) in a patient who received intrathecal stem cell injections at an unregulated clinic, confirming tumor formation as a documented complication.

  • JAMA Internal Medicine (Bauer et al., 2018)

    Analysis of FDA adverse event reports and MedWatch data confirmed documented harms from unregulated stem cell clinics including infections, neurological complications, and vision loss across multiple patients.

TellWell AI

Related debunks